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Identity 
Other names: EIF3; EIF3S10; KIAA0139; P167; 
TIF32; eIF3-p170; eIF3-theta; p180; p185 




The eIF3a gene spans over a region of 46 kbp DNA 
including 22 coding exons and 2 non-coding exons 
(exon 2 and exon 10). 
Transcription 
The eIF3a mRNA consists of about 5256 nucleotides 
with an open reading frame (ORF) of 4149 bases. 
Pseudogene 
No pseudogene has been identified. 
Protein 
Description 
Structure: The eIF3a protein consists of 1382 amino 
acid residues with an apparent molecular weight of 
~170 kDa as determined using SDS-PAGE (Pincheira 
et al., 2001b). Its primary sequence contains a PCI
(Proteasome, COP9, Initiation factor 3) domain, a  
spectrin domain, and a 10-amino acid repeat domain 
(Pincheira et al., 2001b). It has phosphorylation sites at 
Ser-881, Ser-1198, Ser-1336 and Ser-1364 (Damoc et 
al., 2007). The PCI domain spans from amino acid 405 
to 495, which contains purely alpha-helix (Pincheira et 
al., 2001b). Since most of the proteins containing this
domain are part of a multi-protein complex, it is 
tempting to speculate that this domain may be involved 
in the interaction of eIF3a with other molecules in eIF3 
(Hofmann and Bucher, 1998). The spectrin domain, 
which consists of 112 amino acids, is a sequence 
almost identical to spectrin, an actin-binding protein 
(Pascual et al., 1997). Although the exact function of 
this domain remains unknown, it may be responsible 
for the binding of eIF3a to actin filaments (Pincheira et 
al., 2001a). The 10-amino acid repeat domain spanning 
925-1172 amino acids is the largest domain of eIF3a. It 
can be divided into about 25 repeats of 
DDDRGPRRGA (Johnson et al., 1997; Pincheira et al., 
2001b). This domain has been suggested to contribute 
to interaction of eIF4B and eIF3a (Methot et al., 1996). 
Regulatory role in gene expression: eIF3a not only 
functions as a regular translation initiation factor and 
participates in translation initiation of global mRNAs, it 
also regulates the translation of a subset of mRNAs 
which are involved in cell cycle, tumorigenesis and 
DNA repair (Yin et al., 2010). It has been observed that 
overexpression of ectopic eIF3a increases the 
expression of ribonucleotide reductase 
 
Schematic presentation of eIF3a domain structure. Human eIF3a consists of 1382 amino acid residues with three putative domains of 
PCI, spectrin, and 10-amino acid repeat. 
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M2 (RRM2) and alpha-tubulin, but decreases that of 
p27kip without affect their mRNA levels (Dong and 
Zhang, 2003; Dong et al., 2004). Recently, it has also 
been found that eIF3a suppresses the synthesis of DNA 
repair proteins including: XPA, XPC, RPA 14, RPA 32 
and RPA 70 KDa (Yin et al., unpublished data). 
Although the detailed mechanism of eIF3a regulation 
in translational control is yet to be determined, it is 
thought that eIF3a may regulate these genes at their 5'- 
and 3'-UTRs (Dong and Zhang, 2003; Dong et al., 
2004). 
Binding with other molecule: Since eIF3a is the 
largest subunit of the eIF3 complex, the interaction 
between eIF3a and other subunits of eIF3 were 
intensively studied. It can bind with eIF3b (Methot et 
al., 1997), eIF3c (Valasek et al., 2002), eIF3f (Asano et 
al., 1997), eIF3h (Asano et al., 1997), eIF3j (Valasek et 
al., 1999) and eIF3k (Mayeur et al., 2003). During the
translation initiation, the amino terminal domain of 
eIF3a can bind with 40S protein RPS0A, while the C 
terminal domain binds with the 18S rRNA (Valasek et 
al., 2003). Apart from above molecule, eIF3a has also 
been shown to interact with eIF4B (Methot et al., 
1996), actin (Pincheira et al., 2001a), and cytokeratin 7 
(Lin et al., 2001). 
Expression 
eIF3a is ubiquitously expressed in all human tissue 
(Nagase et al., 1995; Scholler and Kanner, 1997; 
Pincheira et al., 2001b). However, its expression is 
higher in proliferating tissues such as bone marrow, 
thymus and fetal tissues (Pincheira et al., 2001b). 
Localisation 
eIF3a has been found in both cytoplasmic and 
membrane fractions and the cytoplasmic eIF3a appears 
to be phosphorylated at its serine residues (Pinchera et 
al., 2001a). However, 70-80% of eIF3a is cytoplasmic. 
Function 
eIF3a has been shown to play important roles in the 
biological processes: translational initiation (including 
generation of ribosomal subunit from 80S ribosomes, 
43S pre-initiation complex formation and 48S pre-
initiation complex formation) (Dong and Zhang, 2006), 
regulation of mRNA translation (Dong and Zhang, 
2003; Dong et al., 2004), differentiation and 
development (Liu et al., 2007), apoptosis (Nakai et al., 
2005), cell cycle regulation (Dong et al., 2009), 
oncogenesis (Dong and Zhang, 2006; Zhang et al., 
2007), and drug response (unpublished observations). 
Homology 
Centrosomin A and B have strong homology to eIF3a.  
The spectrin domain is essentially identical to spectrin. 
Mutations 
Note 
Two SNPs (rs10787899 and rs3824830) were found to 
be associated with higher risk of breast cancers (Ol on 




eIF3a was overexpressed in breast cancer tissues. 
Oncogenesis 
The eIF3a was highly expressed in all tested tissues 
from breast cancer patients compared with normal 
control tissues, which indicated that it may contribute 




eIF3a was found to be a molecular parameter of 
predicting cervical carcinoma progression and 
prognoses. 
Prognosis 
Patients with high eIF3a expression have better 
prognosis than those with lower ones, thus it will be 




eIF3a is an early tumor maker of gastric carcinoma. 
Oncogenesis 
eIF3a was highly expressed in well differentiated, arly 
invasive stage and no-metastases gastric carcinoma 
(Chen and Burger, 2004). 
Lung cancer 
Note 
eIF3a is highly expressed in lung cancer compared with 
normal tissues. 
Prognosis 
eIF3a expression in human lung cancers negatively 
correlates with patient response to platinum-based 
chemotherapy, suggesting that lung cancer patients 
with higher eIF3a expression level respond better to 
platinum-based chemotherapy (Yin et al., unpublished 
findings). 
Oncogenesis 
eIF3a was over-expressed in all types of human lung
cancer. Furthermore, it is ubiquitously highly  
expressed in proliferating and developing tissues. This 
suggested eIF3a may be involved in oncogenesis of 
lung cancer (Pincheira et al., 2001b). 
Esophagus squamous-cell carcinoma 
Note 
eIF3a may be a biomaker of esophagus squamous-cell 
carcinoma. 
Prognosis 
Patients with higher eIF3a expression have better 






Atlas Genet Cytogenet Oncol Haematol. 2011; 15(7)  546 
overall survival and fewer tumor metastases than those 
with lower ones (Chen and Burger, 1999). 
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